Valneva SE (EPA:VLA)
2.414
+0.034 (1.43%)
Apr 28, 2026, 5:35 PM CET
Valneva SE Employees
Valneva SE had 674 employees as of December 31, 2025. The number of employees decreased by 39 or -5.47% compared to the previous year.
Employees
674
Change (1Y)
-39
Growth (1Y)
-5.47%
Revenue / Employee
€259,138
Profits / Employee
€170,908
Market Cap
419.44M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Genfit | 188 |
| Cellectis | 229 |
| Transgene | 145 |
| MedinCell | 145 |
| Sensorion | 63 |
| Inventiva | 77 |
| DBV Technologies | 117 |
| ABIONYX Pharma | 51 |
Valneva SE News
- 2 hours ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN - GlobeNewsWire
- 7 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN - GlobeNewsWire
- 12 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN - PRNewsWire
- 25 days ago - Declaration of shares and voting rights of Valneva SE – March 2026 - GlobeNewsWire
- 4 weeks ago - Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC - GlobeNewsWire
- 5 weeks ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN - GlobeNewsWire
- 5 weeks ago - Valneva (VALN) Maintains Buy Rating Despite Vaccine Trial Challenges - GuruFocus
- 5 weeks ago - An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive - WSJ